Justin Thompson
Corporate Officer/Principal chez CINCOR PHARMA, INC.
Profil
Justin Thompson is currently working as the Vice President-Business Development at CinCor Pharma, Inc. Prior to this, he worked as an Investment Associate at CincyTech LLC.
Mr. Thompson completed his undergraduate degree from Washington University in St. Louis and his graduate degree from the University of Cincinnati (Ohio).
Postes actifs de Justin Thompson
| Sociétés | Poste | Début |
|---|---|---|
| CINCOR PHARMA, INC. | Corporate Officer/Principal | 01/08/2021 |
Anciens postes connus de Justin Thompson
| Sociétés | Poste | Fin |
|---|---|---|
CincyTech LLC
 CincyTech LLC Investment ManagersFinance CincyTech LLC (CincyTech) is a venture capital firm founded in 2007. The firm is headquartered in Cincinnati, Ohio. | Private Equity Analyst | - |
Formation de Justin Thompson
| Washington University in St. Louis | Undergraduate Degree |
| University of Cincinnati (Ohio) | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CincyTech LLC
CincyTech LLC Investment ManagersFinance CincyTech LLC (CincyTech) is a venture capital firm founded in 2007. The firm is headquartered in Cincinnati, Ohio. | Finance |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
